BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 18722051)

  • 1. A novel and effective hepatocyte growth factor kringle 1 domain and p53 cocktail viral gene therapy for the treatment of hepatocellular carcinoma.
    Shen Z; Wong OG; Yao RY; Liang J; Kung HF; Lin MC
    Cancer Lett; 2008 Dec; 272(2):268-76. PubMed ID: 18722051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The kringle 1 domain of hepatocyte growth factor has antiangiogenic and antitumor cell effects on hepatocellular carcinoma.
    Shen Z; Yang ZF; Gao Y; Li JC; Chen HX; Liu CC; Poon RT; Fan ST; Luk JM; Sze KH; Li TP; Gan RB; He ML; Kung HF; Lin MC
    Cancer Res; 2008 Jan; 68(2):404-14. PubMed ID: 18199534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AAV-HGFK1 and Ad-p53 cocktail therapy prolongs survival of mice with colon cancer.
    Nie B; Shen Z; Wen JB; Wong OG; Hsueh WD; Huo LF; Kung HF; Jiang B; Lin MC
    Mol Cancer Ther; 2008 Sep; 7(9):2855-65. PubMed ID: 18790766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adeno-associated virus-mediated expression of apolipoprotein (a) kringles suppresses hepatocellular carcinoma growth in mice.
    Lee K; Yun ST; Kim YG; Yoon Y; Jo EC
    Hepatology; 2006 May; 43(5):1063-73. PubMed ID: 16628632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic bone marrow transplantation for hepatocellular carcinoma: hepatocyte growth factor suppresses graft-vs.-host disease.
    Yoshida Y; Hirano T; Son G; Iimuro Y; Imado T; Iwasaki T; Fujimoto J
    Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1114-23. PubMed ID: 17761834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HGFK1 inhibits bone metastasis in breast cancer through the TAK1/p38 MAPK signaling pathway.
    Yao Y; Fang ZP; Chen H; Yue L; Min DL; Tang LN; Yu WX; Kung HF; Lin MC; Shen Z
    Cancer Gene Ther; 2012 Sep; 19(9):601-8. PubMed ID: 22767217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent antitumor effect of TRAIL mediated by a novel adeno-associated viral vector targeting to telomerase activity for human hepatocellular carcinoma.
    Wang Y; Huang F; Cai H; Zhong S; Liu X; Tan WS
    J Gene Med; 2008 May; 10(5):518-26. PubMed ID: 18338833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of angiogenesis and HGF-cMET-elicited malignant processes in human hepatocellular carcinoma cells using adenoviral vector-mediated NK4 gene therapy.
    Heideman DA; Overmeer RM; van Beusechem VW; Lamers WH; Hakvoort TB; Snijders PJ; Craanen ME; Offerhaus GJ; Meijer CJ; Gerritsen WR
    Cancer Gene Ther; 2005 Dec; 12(12):954-62. PubMed ID: 15905856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene transfer of kringle 1-5 suppresses tumor development and improves prognosis of mice with hepatocellular carcinoma.
    Torimura T; Ueno T; Kin M; Taniguchi E; Nakamura T; Inoue K; Sakata R; Hashimoto O; Sakamoto M; Ohira H; Kumashiro R; Sata M; Yano H; Kojiro M; Veitonmaki N; Cao Y
    Gastroenterology; 2006 Apr; 130(4):1301-10. PubMed ID: 16618420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.
    Goto T; Ishikawa H; Matsumoto K; Nishimura D; Kusaba M; Taura N; Shibata H; Miyaaki H; Ichikawa T; Hamasaki K; Nakao K; Maeshima Y; Eguchi K
    Int J Oncol; 2008 Jul; 33(1):33-40. PubMed ID: 18575748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 gene therapy in a rat model of hepatocellular carcinoma: intra-arterial delivery of a recombinant adenovirus.
    Anderson SC; Johnson DE; Harris MP; Engler H; Hancock W; Huang WM; Wills KN; Gregory RJ; Sutjipto S; Wen SF; Lofgren S; Shepard HM; Maneval DC
    Clin Cancer Res; 1998 Jul; 4(7):1649-59. PubMed ID: 9676839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased efficacy and safety in the treatment of experimental liver cancer with a novel adenovirus-alphavirus hybrid vector.
    Guan M; Rodriguez-Madoz JR; Alzuguren P; Gomar C; Kramer MG; Kochanek S; Prieto J; Smerdou C; Qian C
    Cancer Res; 2006 Feb; 66(3):1620-9. PubMed ID: 16452221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpressing kringle 1 domain of hepatocyte growth factor with adeno-associated virus inhibits the pathological retinal neovascularization in an oxygen-induced retinopathy mouse model.
    Sun P; Liu Z
    Biochem Biophys Res Commun; 2019 Jan; 508(1):130-137. PubMed ID: 30471863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-tumor effect of E1B55kDa-deleted adenovirus on human hepatocellular carcinoma cell lines].
    Zhao J; Lü Y; Guo Y
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):366-8. PubMed ID: 11810762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus.
    Habib NA; Mitry RR; Sarraf CE; Jiao LR; Havlík R; Nicholls J; Jensen SL
    Cancer Gene Ther; 2002 May; 9(5):414-20. PubMed ID: 11961664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockage of HGF/c-Met system by gene therapy (adenovirus-mediated NK4 gene) suppresses hepatocellular carcinoma in mice.
    Son G; Hirano T; Seki E; Iimuro Y; Nukiwa T; Matsumoto K; Nakamura T; Fujimoto J
    J Hepatol; 2006 Nov; 45(5):688-95. PubMed ID: 16839638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum response factor depletion affects the proliferation of the hepatocellular carcinoma cells HepG2 and JHH6.
    Farra R; Dapas B; Pozzato G; Giansante C; Heidenreich O; Uxa L; Zennaro C; Guarnieri G; Grassi G
    Biochimie; 2010 May; 92(5):455-63. PubMed ID: 20144681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro gene therapy of hepatocellular carcinoma using replication-defective and tumor-specific replication-competent adenovirus carrying interleukin-12 gene].
    Wang XH; Yang JM; Cui ZF; Wang WG; Wu MC; Qian QJ
    Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):581-4. PubMed ID: 15634515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different tumoricidal effects of interferon subclasses and p53 status on hepatocellular carcinoma development and neovascularization.
    Noguchi R; Yoshiji H; Ikenaka Y; Kitade M; Kaji K; Yoshi J; Yanase K; Namisaki T; Yamazaki M; Tsujimoto T; Akahane T; Uemura M; Fukui H
    Int J Oncol; 2008 Jan; 32(1):193-9. PubMed ID: 18097559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High volume hydrodynamic injection of plasmid DNA via the hepatic artery results in a high level of gene expression in rat hepatocellular carcinoma induced by diethylnitrosamine.
    Tada M; Hatano E; Taura K; Nitta T; Koizumi N; Ikai I; Shimahara Y
    J Gene Med; 2006 Aug; 8(8):1018-26. PubMed ID: 16779866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.